SFA Therapeutics is a developer of drugs to treat chronic inflammatory diseases.
SFA Therapeutics's investors include Y Combinator, Acequia Capital (AceCap), Ben Franklin Technology Partners of Southeastern Pennsylvania, Reinforced Ventures, Boost VC.
SFA Therapeutics is headquartered in Jenkintown, United States.
SFA Therapeutics is a developer of drugs to treat chronic inflammatory diseases.
SFA Therapeutics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SFA Therapeutics — Funding & Investors." VCBacked, November 9, 2023, https://www.vcbacked.co/company/sfa-therapeutics. Accessed July 22, 2026.
VCBacked. (2023). SFA Therapeutics — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/sfa-therapeutics
{{cite web |title=SFA Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sfa-therapeutics |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated